Amgen Inc. (United States)

Amgen Inc. is one of the world’s largest biotechnology companies, headquartered in Thousand Oaks, California. Amgen discovers, develops, and manufactures innovative human therapeutics for serious illnesses including cancer, cardiovascular disease, bone health, inflammation, and rare diseases. Key products include Enbrel (etanercept) for autoimmune conditions, Prolia and XGEVA (denosumab) for bone health, Repatha (evolocumab) for high cholesterol, Neulasta and Neupogen for chemotherapy support, and Otezla for psoriasis. Amgen’s biosimilar portfolio and oncology pipeline continue expanding treatment options for patients worldwide.